| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Microfluidic Perfusion Platform for In Vitro Analysis of Drug Pharmacokinetic-Pharmacodynamic (PK-PD) Relationships
|
Guerrero, Yadir A.
|
|
|
22 |
2 |
|
artikel
|
| 2 |
A Microfluidic Perfusion Platform for In Vitro Analysis of Drug Pharmacokinetic-Pharmacodynamic (PK-PD) Relationships
|
Guerrero, Yadir A.
|
|
|
22 |
2 |
|
artikel
|
| 3 |
An Agent-Based Systems Pharmacology Model of the Antibody-Drug Conjugate Kadcyla to Predict Efficacy of Different Dosing Regimens
|
Menezes, Bruna
|
|
|
22 |
2 |
|
artikel
|
| 4 |
Antibody Coadministration as a Strategy to Overcome Binding-Site Barrier for ADCs: a Quantitative Investigation
|
Singh, Aman P.
|
|
|
22 |
2 |
|
artikel
|
| 5 |
Application of Reticulocyte-Based Estimation of Red Blood Cell Lifespan in Anemia Management of End-Stage Renal Disease Patients
|
Nguyen, Ly Minh
|
|
|
22 |
2 |
|
artikel
|
| 6 |
Application of Reticulocyte-Based Estimation of Red Blood Cell Lifespan in Anemia Management of End-Stage Renal Disease Patients
|
Nguyen, Ly Minh
|
|
|
22 |
2 |
|
artikel
|
| 7 |
Bayesian Individual Dynamic Predictions with Uncertainty of Longitudinal Biomarkers and Risks of Survival Events in a Joint Modelling Framework: a Comparison Between Stan, Monolix, and NONMEM
|
Riglet, François
|
|
|
22 |
2 |
|
artikel
|
| 8 |
Bayesian Individual Dynamic Predictions with Uncertainty of Longitudinal Biomarkers and Risks of Survival Events in a Joint Modelling Framework: a Comparison Between Stan, Monolix, and NONMEM
|
Riglet, François
|
|
|
22 |
2 |
|
artikel
|
| 9 |
Biopharmaceutical Understanding of Excipient Variability on Drug Apparent Solubility Based on Drug Physicochemical Properties: Case Study—Hypromellose (HPMC)
|
Zarmpi, P.
|
|
|
22 |
2 |
|
artikel
|
| 10 |
Biopharmaceutical Understanding of Excipient Variability on Drug Apparent Solubility Based on Drug Physicochemical Properties: Case Study—Hypromellose (HPMC)
|
Zarmpi, P.
|
|
|
22 |
2 |
|
artikel
|
| 11 |
Biopharmaceutical Understanding of Excipient Variability on Drug Apparent Solubility Based on Drug Physicochemical Properties. Case Study: Superdisintegrants
|
Zarmpi, Panagiota
|
|
|
22 |
2 |
|
artikel
|
| 12 |
Biopharmaceutical Understanding of Excipient Variability on Drug Apparent Solubility Based on Drug Physicochemical Properties. Case Study: Superdisintegrants
|
Zarmpi, Panagiota
|
|
|
22 |
2 |
|
artikel
|
| 13 |
Co-administration of Paediatric Medicines with Food and Drinks in the Context of Their Physicochemical Properties—a Global Perspective on Practices and Recommendations
|
Martir, Joana
|
|
|
22 |
2 |
|
artikel
|
| 14 |
Co-administration of Paediatric Medicines with Food and Drinks in the Context of Their Physicochemical Properties—a Global Perspective on Practices and Recommendations
|
Martir, Joana
|
|
|
22 |
2 |
|
artikel
|
| 15 |
Considerations for Soluble Protein Biomarker Blood Sample Matrix Selection
|
Mathews, Joel A.
|
|
|
22 |
2 |
|
artikel
|
| 16 |
Correction to: Fit-for-Purpose Quality Control System in Continuous Bioanalysis during Long-Term Pediatric Studies
|
Ali, Mohsin
|
|
|
22 |
2 |
|
artikel
|
| 17 |
Correction to: Recommendations for the Development of Cell-Based Anti-Viral Vector Neutralizing Antibody Assays
|
Gorovits, Boris
|
|
|
22 |
2 |
|
artikel
|
| 18 |
Correction to: Recommendations for the Development of Cell-Based Anti-Viral Vector Neutralizing Antibody Assays
|
Gorovits, Boris
|
|
|
22 |
2 |
|
artikel
|
| 19 |
Criteria to Reevaluate Anti-drug Antibody Assay Cut Point Suitability in the Target Population
|
Tan, Charles Y.
|
|
|
22 |
2 |
p. 1-3
|
artikel
|
| 20 |
Criteria to Reevaluate Anti-drug Antibody Assay Cut Point Suitability in the Target Population
|
Tan, Charles Y.
|
|
|
22 |
2 |
|
artikel
|
| 21 |
Demonstrating Contribution of Components of Fixed-Dose Drug Combinations Through Longitudinal Exposure-Response Analysis
|
Nøhr-Nielsen, Asbjørn
|
|
|
22 |
2 |
|
artikel
|
| 22 |
Development and Utility of an ELISA Method for Sensitive and Specific Detection of IgE Antidrug Antibodies
|
Zhong, Zhandong Don
|
|
|
22 |
2 |
|
artikel
|
| 23 |
Development of a Cell-Based Assay for the Detection of Neutralizing Antibodies to PF-06730512 Using Homogenous Time-Resolved Fluorescence
|
Luong, Michael
|
|
|
22 |
2 |
|
artikel
|
| 24 |
Development of an Aerosol Dose Collection Apparatus for In Vitro Dissolution Measurements of Orally Inhaled Drug Products
|
Price, Robert
|
|
|
22 |
2 |
|
artikel
|
| 25 |
Development of an Aerosol Dose Collection Apparatus for In Vitro Dissolution Measurements of Orally Inhaled Drug Products
|
Price, Robert
|
|
|
22 |
2 |
|
artikel
|
| 26 |
Development of a Population Pharmacokinetics-Based in vitro-in vivo Correlation Model for Drugs with Site-Dependent Absorption: the Acyclovir Case Study
|
Shin, Soyoung
|
|
|
22 |
2 |
|
artikel
|
| 27 |
Dose Correction for a Michaelis–Menten Approximation of a Target-Mediated Drug Disposition Model with a Multiple Intravenous Dosing Regimens
|
Yan, Xiaoyu
|
|
|
22 |
2 |
|
artikel
|
| 28 |
Estimation of the Effect of OAT2-Mediated Active Uptake on Meloxicam Exposure in the Human Liver
|
Li, Rui
|
|
|
22 |
2 |
p. 1-9
|
artikel
|
| 29 |
Estimation of the Effect of OAT2-Mediated Active Uptake on Meloxicam Exposure in the Human Liver
|
Li, Rui
|
|
|
22 |
2 |
|
artikel
|
| 30 |
Expert Discussion of the Role of Rate Constant Versus Clearance Approaches to Define Drug Pharmacokinetics: Theoretical and Clinical Considerations
|
Martinez, Marilyn N.
|
|
|
22 |
2 |
p. 1-12
|
artikel
|
| 31 |
Expert Discussion of the Role of Rate Constant Versus Clearance Approaches to Define Drug Pharmacokinetics: Theoretical and Clinical Considerations
|
Martinez, Marilyn N.
|
|
|
22 |
2 |
|
artikel
|
| 32 |
Global Sensitivity Analysis of the Rodgers and Rowland Model for Prediction of Tissue: Plasma Partitioning Coefficients: Assessment of the Key Physiological and Physicochemical Factors That Determine Small-Molecule Tissue Distribution
|
Yau, Estelle
|
|
|
22 |
2 |
|
artikel
|
| 33 |
Global Sensitivity Analysis of the Rodgers and Rowland Model for Prediction of Tissue: Plasma Partitioning Coefficients: Assessment of the Key Physiological and Physicochemical Factors That Determine Small-Molecule Tissue Distribution
|
Yau, Estelle
|
|
|
22 |
2 |
|
artikel
|
| 34 |
Immunogenicity Risk Assessment for PEGylated Therapeutics
|
Mora, Johanna R.
|
|
|
22 |
2 |
|
artikel
|
| 35 |
Investigation on the Effect of Capillary Microsampling on Hematologic and Toxicokinetic Evaluation in Regulatory Safety Studies in Mice
|
Wang, Bonnie
|
|
|
22 |
2 |
|
artikel
|
| 36 |
Investigations of Piperazine Derivatives as Intestinal Permeation Enhancers in Isolated Rat Intestinal Tissue Mucosae
|
Stuettgen, V.
|
|
|
22 |
2 |
|
artikel
|
| 37 |
Mechanistic Pharmacokinetic/Pharmacodynamic Model of Sunitinib and Dopamine in MCF-7/Adr Xenografts: Linking Cellular Heterogeneity to Tumour Burden
|
Wang, Siyuan
|
|
|
22 |
2 |
|
artikel
|
| 38 |
Mechanistic Pharmacokinetic/Pharmacodynamic Model of Sunitinib and Dopamine in MCF-7/Adr Xenografts: Linking Cellular Heterogeneity to Tumour Burden
|
Wang, Siyuan
|
|
|
22 |
2 |
|
artikel
|
| 39 |
Model Averaging in Viral Dynamic Models
|
Gonçalves, Antonio
|
|
|
22 |
2 |
|
artikel
|
| 40 |
Model Averaging in Viral Dynamic Models
|
Gonçalves, Antonio
|
|
|
22 |
2 |
|
artikel
|
| 41 |
Model-Based Characterization of the Pharmacokinetics, Target Engagement Biomarkers, and Immunomodulatory Activity of PF-06342674, a Humanized mAb Against IL-7 Receptor-α, in Adults with Type 1 Diabetes
|
Williams, Jason H.
|
|
|
22 |
2 |
p. 1-12
|
artikel
|
| 42 |
Model-Based Characterization of the Pharmacokinetics, Target Engagement Biomarkers, and Immunomodulatory Activity of PF-06342674, a Humanized mAb Against IL-7 Receptor-α, in Adults with Type 1 Diabetes
|
Williams, Jason H.
|
|
|
22 |
2 |
|
artikel
|
| 43 |
Physiologically Based Pharmacokinetic Modeling and Simulation of Sunitinib in Pediatrics
|
Yu, Yanke
|
|
|
22 |
2 |
|
artikel
|
| 44 |
Physiologically Based Pharmacokinetic Modeling and Tissue Distribution Characteristics of SHetA2 in Tumor-Bearing Mice
|
Sharma, Ankur
|
|
|
22 |
2 |
|
artikel
|
| 45 |
Physiologically Based Pharmacokinetic Modeling and Tissue Distribution Characteristics of SHetA2 in Tumor-Bearing Mice
|
Sharma, Ankur
|
|
|
22 |
2 |
|
artikel
|
| 46 |
Physiologically Based Pharmacokinetic Model to Support Ophthalmic Suspension Product Development
|
Le Merdy, Maxime
|
|
|
22 |
2 |
p. 1-10
|
artikel
|
| 47 |
Physiologically Based Pharmacokinetic Model to Support Ophthalmic Suspension Product Development
|
Le Merdy, Maxime
|
|
|
22 |
2 |
|
artikel
|
| 48 |
Polymeric Nanocarrier Formulations of Biologics Using Inverse Flash NanoPrecipitation
|
Markwalter, Chester E.
|
|
|
22 |
2 |
p. 1-16
|
artikel
|
| 49 |
Polymeric Nanocarrier Formulations of Biologics Using Inverse Flash NanoPrecipitation
|
Markwalter, Chester E.
|
|
|
22 |
2 |
|
artikel
|
| 50 |
Quantification of T Cell Binding Polyclonal Rabbit Anti-thymocyte Globulin in Human Plasma with Liquid Chromatography Tandem-Mass Spectrometry
|
Amrani, Mohsin El
|
|
|
22 |
2 |
|
artikel
|
| 51 |
Quantification of T Cell Binding Polyclonal Rabbit Anti-thymocyte Globulin in Human Plasma with Liquid Chromatography Tandem-Mass Spectrometry
|
Amrani, Mohsin El
|
|
|
22 |
2 |
|
artikel
|
| 52 |
Quantitative Assessment of Pulmonary Targeting of Inhaled Corticosteroids Using Ex Vivo Receptor Binding Studies
|
Shao, Jie
|
|
|
22 |
2 |
|
artikel
|
| 53 |
Quantitative Assessment of Pulmonary Targeting of Inhaled Corticosteroids Using Ex Vivo Receptor Binding Studies
|
Shao, Jie
|
|
|
22 |
2 |
|
artikel
|
| 54 |
Recommendations for the Development of Cell-Based Anti-Viral Vector Neutralizing Antibody Assays
|
Boris, Gorovits
|
|
|
22 |
2 |
p. 1-10
|
artikel
|
| 55 |
Recommendations for the Development of Cell-Based Anti-Viral Vector Neutralizing Antibody Assays
|
Gorovits, Boris
|
|
|
22 |
2 |
|
artikel
|
| 56 |
Recommendations for the Development of Cell-Based Anti-Viral Vector Neutralizing Antibody Assays
|
Gorovits, Boris
|
|
|
22 |
2 |
|
artikel
|
| 57 |
Reference Datasets for Studies in a Replicate Design Intended for Average Bioequivalence with Expanding Limits
|
Schütz, Helmut
|
|
|
22 |
2 |
|
artikel
|
| 58 |
Reference Datasets for Studies in a Replicate Design Intended for Average Bioequivalence with Expanding Limits
|
Schütz, Helmut
|
|
|
22 |
2 |
|
artikel
|
| 59 |
Selection of In Vivo Predictive Dissolution Media Using Drug Substance and Physiological Properties
|
Mudie, Deanna M.
|
|
|
22 |
2 |
|
artikel
|
| 60 |
Systematic Review of Device Parameters and Design of Studies Bridging Biologic-Device Combination Products Using Prefilled Syringes and Autoinjectors
|
Hu, Ping
|
|
|
22 |
2 |
|
artikel
|
| 61 |
Systematic Review of Device Parameters and Design of Studies Bridging Biologic-Device Combination Products Using Prefilled Syringes and Autoinjectors
|
Hu, Ping
|
|
|
22 |
2 |
|
artikel
|
| 62 |
The Evolving Druggability and Developability Space: Chemically Modified New Modalities and Emerging Small Molecules
|
Yang, Wenzhan
|
|
|
22 |
2 |
p. 1-14
|
artikel
|
| 63 |
The Evolving Druggability and Developability Space: Chemically Modified New Modalities and Emerging Small Molecules
|
Yang, Wenzhan
|
|
|
22 |
2 |
|
artikel
|
| 64 |
The Production, Quality Control, and Characterization of ZED8, a CD8-Specific 89Zr-Labeled Immuno-PET Clinical Imaging Agent
|
Gill, Herman
|
|
|
22 |
2 |
p. 1-12
|
artikel
|
| 65 |
The Production, Quality Control, and Characterization of ZED8, a CD8-Specific 89Zr-Labeled Immuno-PET Clinical Imaging Agent
|
Gill, Herman
|
|
|
22 |
2 |
|
artikel
|
Tijdschrift beschrijving